COVID-19, and more rarely the mRNA-based COVID-19 vaccine, can lead to inflammation of heart tissue in some individuals. A ...

Thymagen (also called thymogen; dipeptide Glu-Trp, EW) is a synthetic peptide analog derived from thymic extracts and regarded in peptide bioregulator research for its putative immunoregulatory and ...

Research presented by Professor Cecilia Johansson of Imperial College London has linked early type I interferon signalling in ...

Mondego Bio, a clinical-stage biotechnology company developing next-generation small-molecule immuno-oncology therapies, ...

Myocarditis has become a flashpoint in debates about COVID vaccines; however, new research suggests this rare heart ...

Researchers at the Federal University of São Paulo (UNIFESP) in Brazil have discovered that SARS-CoV-2, the virus that causes COVID-19, uses a sophisticated tactic to evade the human body's defense ...

Researchers at the Federal University of São Paulo (UNIFESP) in Brazil have discovered that SARS-CoV-2, the virus that causes ...

The Stanford summary backs up the "rare" label with specific numbers: about one myocarditis case per 140,000 people after a ...

Infragreen Group Limited ( ($AU:IFN) ) has issued an announcement. Infragreen Group Limited has announced a change in the director’s interest ...

A rapid, two-step immune reaction may underlie rare cases of heart inflammation seen after COVID-19 mRNA vaccination, Stanford University researchers found, shedding light on a mechanism that’s fueled ...

Study points to source of "very, very rare" cases of myocarditis and potential solutions. Myocarditis risk remains far higher ...